CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	3 Months Ended
	Mar. 29, 2014	Mar. 30, 2013
OPERATING ACTIVITIES
Net earnings attributable to common shareowners	$ 161,900,000	$ 81,100,000
Adjustments to reconcile net earnings to cash provided by operating activities:
Depreciation and amortization of property, plant and equipment	64,400,000	58,500,000
Amortization of intangibles	46,000,000	47,300,000
Pretax gain on sale of business	3,100,000	0
Asset Impairment Charges	0	16,500,000
Changes in working capital	(330,300,000)	(195,000,000)
Changes in other assets and liabilities	(97,100,000)	(155,900,000)
Cash provided by operating activities	(152,000,000)	(147,500,000)
INVESTING ACTIVITIES
Capital expenditures	(57,800,000)	(76,600,000)
Payments to Acquire Machinery and Equipment	(4,400,000)	(2,900,000)
Business acquisitions, net of cash acquired	(3,200,000)	(853,900,000)
Proceeds from sale of assets	6,000,000	1,000,000
Proceeds (payments) on net investment hedge settlements	(6,300,000)	(9,200,000)
Cash provided by (used in) investing activities	(65,700,000)	(941,600,000)
FINANCING ACTIVITIES
Payments on long-term debt	(300,000)	(600,000)
Stock purchase contract fees	(3,600,000)	(800,000)
Net short-term borrowings	282,300,000	1,330,500,000
Cash dividends on common stock	(80,700,000)	(79,100,000)
Payments for Repurchase of Equity	0	(350,000,000)
Termination of interest rate swaps	(30,300,000)	0
Proceeds from the issuance of common stock	13,200,000	83,200,000
Purchase of common stock for treasury	(19,400,000)	(21,100,000)
Cash provided by (used in) financing activities	161,200,000	962,100,000
Effect of exchange rate changes on cash and cash equivalents	(7,100,000)	(31,500,000)
Change in cash and cash equivalents	(63,600,000)	(158,500,000)
Cash and cash equivalents, beginning of period	496,200,000
CASH AND CASH EQUIVALENTS, END OF PERIOD	$ 432,600,000	$ 557,500,000